drug delivery

Welcome to DDP

Welcome to the 14th Annual Drug Delivery Partnerships

For the past 13 years, Drug Delivery Partnerships (DDP) has been the global meeting place for the drug delivery industry. Here are 1,033 reasons why the leading participants form Pharma, Biotech, Specialty Pharma, and Generic make this must-attend event.

Hot-Topic Panel Discussions- Ask the Experts Your Most Burning Questions

  • Large Pharma & Their Interactions with Biotech Companies
  • Insights fro VC & Private Equity - How Do you Look For The Next Big Investment Prospect?
  • Needle-Based Systems - A Revolution From Evolutionary Improvements To A Standard Technology
  • Large Pharma & Their Interactions with Biotech Companies
  • Benefits of Optimal Dosing & How To Address Reimbursement Challenges with New, More Costly Delivery Techniques
  • Where Does the Future Lie for Systemic Delivery of Drugs by Inhalation?
  • How Will Novel Drug Delivery Technologies Serve to Address Issues Surrounding Abuse of Pain Products?

In The News

  • Vical's H1N1 vaccines tested
    According to SignOnSanDiego.com, Vical has tested their H1N1 flu vaccines on animals, and found the tests to be successful. Their delivery method is unique, injecting genetic material, such as DNA or RNA, that expresses a protein that induces an imm...
  • Morphotek working with Synageva BioPharma
    The Philadelphia Business Journal reports that Morphotek Inc. said Wednesday that it will collaborate with Synageva BioPharma Corp. on the development of therapeutic monoclonal antibodies for the potential treatment of various forms of cancer and inf...
  • Generic Biotech is Coming to the US
    This post on the Wall Street Journal blog discusses that soon enough generic biotech drugs will be coming to the US. This is evident with the latest deal with Mylan, a Pennsylvania based generics shop, and Biocan, an Indian biotech company.Manufactur...
  • Could drug delivery methods prevent prescription abuse?
    In an article at PharmTech, they look at how changing drug delivery methods could prevent prescription drug abuse. While changing the drug delivery method could stop abusers from taking the prescriptions, it would allow the doses to be available to ...
  • Exclusivity period for biologics
    Obama believes that biologics should be able to face competition after seven years on the market instead of 12-14. Nancy-Ann DeParle, director of the Office of Health Reform, and Peter Orszag, director of the Office of Management and Budget wrote a l...

2009 SPONSORS

CONNECT

Join the DDP Linked In Group

 

 

 

Brochure Register Press Policy Recommend Contact Opt-in Home
© 2008-2009 IIR Holdings, LTD. All Rights Reserved.